Bank of New York Mellon’s NextCure NXTC Stock Holding History

Bank of New York Mellon’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,668	Closed	-$560K	–	4446
2021 Q1	$560K	Sell	4,668 -14	-0.3%	-$2.03K	﹤0.01%	3626
2020 Q4	$613K	Sell	4,682 -259	-5%	-$33.5K	﹤0.01%	3511
2020 Q3	$521K	Sell	4,941 -141	-3%	-$17.3K	﹤0.01%	3467
2020 Q2	$1.31M	Buy	5,082 +928	+22%	+$353K	﹤0.01%	2950
2020 Q1	$1.85M	Buy	4,154 +474	+13%	+$253K	﹤0.01%	2591
2019 Q4	$2.49M	Buy	3,680 +2,445	+198%	+$1.23M	﹤0.01%	2691
2019 Q3	$457K	Buy	+1,235	New	+$402K	﹤0.01%	3581

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's NXTC Position: Q2 2021 in Review

Bank of New York Mellon sold out of NextCure (NXTC) in Q2 2021, closing a stake of 4,668 shares — an estimated $560K sold.

Bank of New York Mellon first reported a position in NXTC in Q3 2019 and held it in 7 quarters. The position peaked at $2.49M in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

Bank of New York Mellon reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
Bank of New York Mellon sold 4,668 NextCure shares in Q2 2021, an estimated $560K.
Bank of New York Mellon first reported a position in NextCure in Q3 2019 and held it in 7 quarters.
Bank of New York Mellon's NextCure position peaked at $2.49M in Q4 2019.
78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.